Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:945-946 (10 November), doi:10.1136/bmj.39337.427500.80 (published 1 November 2007)
Guidelines for primary prevention of cardiovascular disease are appropriate for all women
| The first 150 words of the full text of this article appear below. |
Cardiovascular disease is the leading cause of death in women.1 Although its incidence is declining in men, this is not the case in women.2
Pre-eclampsia is a novel cardiovascular risk marker. Pre-eclampsia increases both the long term risk of cardiovascular disease and the risk that it will occur earlier. This has been shown consistently over time, in different settings, and for coronary and cerebrovascular outcomes. The magnitude of the risk for cardiovascular disease in women with previous pre-eclampsia is similar to that of dysplipidaemia.3 Risk seems to be greater for pre-eclampsia than for gestational (or "pregnancy induced", non-proteinuric) hypertension. Risk is also greater for early-onset pre-eclampsia and for pre-eclampsia associated with placental complications (such as stillbirth or small for gestational age infants).4 Two papers in this week's BMJ assess the link between pre-eclampsia and cardiovascular disease.5 6
In the first paper, Bellamy and colleagues summarise the consistency and strength of the
L A Magee, clinical associate professor of medicine, P von Dadelszen, associate professor of obstetrics and gynaecology
University of British Columbia, Vancouver, BC, Canada
LMagee@cw.bc.ca
Read all Rapid Responses